Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Innovation Pharmaceuticals Inc. | ipix_ex311.htm |
| EX-32.1 - CERTIFICATION - Innovation Pharmaceuticals Inc. | ipix_ex321.htm |
| 10-K - FORM 10-K - Innovation Pharmaceuticals Inc. | ipix_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To Whom It May Concern:
We hereby consent to the use in the annual report of Innovation Pharmaceuticals, Inc., on Form 10-K, filed on September 14, 2020, of our Report of Independent Registered Public Accounting Firm, dated September 14, 2020, on the consolidated balance sheets of Innovation Pharmaceuticals, Inc., as of June 30, 2020 and the related statements of operations, changes in shareholders' deficit and cash flows for the years ended June 30, 2020 and 2019 and the related notes, which appear in the Form 10-K. We also hereby consent to the incorporation by reference in the registration statements on Form S-3 (File No. 333-220419) and Form S-8 (File Nos. 333-212549 and 333-212551) of the foregoing Report of Independent Registered Public Accounting Firm.
/s/ Pinnacle Accountancy Group of Utah
Pinnacle Accountancy Group of Utah
Farm